Senseonics Holdings, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Senseonics Holdings, Inc. filed its Q1 2024 10-Q, detailing financial positions and equity plans.</b>

AI Summary

Senseonics Holdings, Inc. (SENS) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Senseonics Holdings, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing includes financial data for the first quarter of 2024. Key financial statement items such as common stock, preferred stock, retained earnings, additional paid-in capital, and accumulated other comprehensive income are detailed as of March 31, 2024. The company has various equity incentive plans and stock purchase plans, with details provided for the period ending March 31, 2024. The filing references agreements with entities such as Hercules Capital Inc. and Jefferies LLC, with associated dates.

Why It Matters

For investors and stakeholders tracking Senseonics Holdings, Inc., this filing contains several important signals. This 10-Q filing provides investors with the latest financial snapshot of Senseonics Holdings, Inc., crucial for understanding the company's performance and financial health in early 2024. The detailed breakdown of equity and liabilities, along with references to financing agreements, offers insights into the company's capital structure and ongoing financial strategies.

Risk Assessment

Risk Level: — Senseonics Holdings, Inc. shows moderate risk based on this filing. The company's financial health and operational status are detailed in this 10-Q, which is a standard regulatory filing. Specific financial figures and risk factors, if detailed in the full report, would determine the precise risk level.

Analyst Insight

Review the detailed financial statements and risk factors within the full 10-Q filing to assess Senseonics Holdings, Inc.'s current financial standing and future prospects.

Key Numbers

• 2024-03-31 — Period End Date (Conformed period of report)
• 2024-05-13 — Filing Date (Filed as of date)

Key Players & Entities

• Senseonics Holdings, Inc. (company) — Filer name
• 2024-03-31 (date) — Conformed period of report
• 2024-05-13 (date) — Filed as of date
• Hercules Capital Inc. (company) — Entity referenced in relation to financial agreements
• Jefferies LLC (company) — Entity referenced in relation to financial agreements
• Goldman Sachs LLC (company) — Entity referenced in relation to financial agreements

FAQ

Industry Context

Senseonics Holdings, Inc. operates in the medical device industry, specifically focusing on implantable continuous glucose monitoring systems.

Regulatory Implications

As a publicly traded company, Senseonics Holdings, Inc. is subject to the reporting requirements of the Securities and Exchange Commission (SEC), including the filing of quarterly reports (10-Q).

What Investors Should Do

1. Analyze the detailed financial statements within the 10-Q for revenue, expenses, and cash flow.
2. Examine the notes to the financial statements for further details on accounting policies, debt, and equity.
3. Review any disclosed risk factors or management's discussion and analysis for insights into business challenges and strategies.

Year-Over-Year Comparison

This is the 10-Q filing for the period ending March 31, 2024, providing updated financial information compared to previous filings.

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value SENS NYSE American Indi
• $0 — 6,421 shares of common stock, par value $0.001, outstanding as of May 10, 2024. T

Filing Documents

• sens-20240331x10q.htm (10-Q) — 1486KB
• sens-20240331xex31d1.htm (EX-31.1) — 12KB
• sens-20240331xex31d2.htm (EX-31.2) — 12KB
• sens-20240331xex32d1.htm (EX-32.1) — 9KB
• 0001558370-24-007966.txt (&nbsp;) — 7768KB
• sens-20240331.xsd (EX-101.SCH) — 57KB
• sens-20240331_cal.xml (EX-101.CAL) — 65KB
• sens-20240331_def.xml (EX-101.DEF) — 249KB
• sens-20240331_lab.xml (EX-101.LAB) — 499KB
• sens-20240331_pre.xml (EX-101.PRE) — 384KB
• sens-20240331x10q_htm.xml (XML) — 1320KB

: Financial Information

PART I: Financial Information

: Financial Statements

ITEM 1 : Financial Statements Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March 31, 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) for the three months ended March 31, 2024 and 2023 5 Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 6 Notes to Unaudited Condensed Consolidated Financial Statements 7

: Management's Discussion and Analysis of Financial Condition and Results of Operations

ITEM 2 : Management's Discussion and Analysis of Financial Condition and Results of Operations 26

: Quantitative and Qualitative Disclosures About Market Risk

ITEM 3 : Quantitative and Qualitative Disclosures About Market Risk 36

: Controls and Procedures

ITEM 4 : Controls and Procedures 36

: Other Information

PART II : Other Information 37

: Legal Proceedings

ITEM 1 : Legal Proceedings 37

: Risk Factors

ITEM 1A: Risk Factors 37

: Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2 : Unregistered Sales of Equity Securities and Use of Proceeds 39

: Defaults Upon Senior Securities

ITEM 3 : Defaults Upon Senior Securities 39

: Mine Safety Disclosures

ITEM 4 : Mine Safety Disclosures 39

: Other Information

ITEM 5 : Other Information 39

: Exhibits

ITEM 6 : Exhibits 40

SIGNATURES

SIGNATURES 41 2 Table of Contents Senseonics Holdings, Inc. Condensed Consolidated Balance Sheet s (in thousands, except share and per share data) March 31, December 31, 2024 2023 (unaudited) Assets Current assets: Cash and cash equivalents $ 90,544 $ 75,709 Restricted cash 316 — Short term investments, net 8,169 33,747 Accounts receivable, net 1,001 808 Accounts receivable, net - related parties 2,750 3,724 Inventory, net 7,963 8,776 Prepaid expenses and other current assets 7,434 7,266 Total current assets 118,177 130,030 Deposits and other assets 6,903 7,006 Property and equipment, net 1,436 1,184 Total assets $ 126,516 $ 138,220 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 675 $ 4,568 Accrued expenses and other current liabilities 10,034 11,744 Accrued expenses and other current liabilities, related parties 1,071 945 Note payable, current portion, net 17,937 — Derivative liability, current portion 102 — Total current liabilities 29,819 17,257 Long-term debt and notes payables, net 33,965 41,195 Derivative liabilities — 102 Other liabilities 6,114 6,214 Total liabilities 69,898 64,768 Preferred stock and additional paid-in-capital, subject to possible redemption: $ 0.001 par value per share; 12,000 shares and 12,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023 37,656 37,656 Total temporary equity 37,656 37,656 Commitments and contingencies Stockholders' equity: Common stock, $ 0.001 par value per share; 900,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 530,817,549 shares and 530,364,237 shares issued and outstanding as of March 31, 2024 and December 31, 2023 530 530 Additional paid-in capital 906,569 904,535 Accumulated other comprehensive loss ( 2 ) ( 11 ) Accumulated deficit ( 888,135 ) ( 869,258 ) Total stockholders'

View Full Filing

View this 10-Q filing on SEC EDGAR